Public distrust in the government, fueled by the Trump administration's data handling, is causing a decline in U.S. Census participation. Experts warn that this could lead to skewed statistics and affect federal funding allocations.
Anthropic has made web search available to all free users of its AI chatbot Claude, enhancing response accuracy. Plus, voice mode is in beta, allowing natural conversations with five voice options.
Microsoft's new AI model, Aurora, promises to revolutionize weather forecasting by predicting hurricanes and other atmospheric events with unprecedented accuracy and speed. Discover how this technology outperforms traditional methods!
A groundbreaking blood test cleared by the FDA offers a new way to diagnose Alzheimer's disease, improving accuracy and accessibility for millions. Experts believe this innovation will enhance patient care and early intervention.
Garmin's latest Forerunner 970 and 570 models come with a hefty price tag, but do the new features justify the cost? Discover how Garmin's pricing strategy impacts its mid-tier offerings.
Google is giving Pixel Watches a vibrant makeover with Wear OS 6! Expect smoother transitions, engaging Tiles, and the introduction of Gemini as your new assistant. Will this redesign win over core Pixel fans?
Sony has launched the WH-1000XM6, a flagship in wireless noise-canceling headphones, boasting superior audio quality, improved ANC, and a sleek new design. Priced at $450, are these upgrades worth it?
Google is set to revamp its Find My Device network as it introduces ultra wideband (UWB) support for better tracking. Rebranded as Find Hub, this update aims to enhance accuracy and user experience, putting pressure on competitors like Apple and Samsung.
A new tool from the University of Washington could change how we assess health by predicting biological age and risk of disability. The Health Octo Tool uses eight metrics to provide insights into aging and potentially improve health outcomes.
A groundbreaking urine test for prostate cancer has shown remarkable accuracy, outperforming traditional blood tests. Set to enter clinical trials, this innovation may make routine screenings a reality, potentially saving thousands of lives.
